Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis

Molecular Imaging

Volumn 9, Issue 5, 2010, Pages 268-277

  Oude Engberink, Raoul D ^a,b,c,d,e   Van Der Pol, Susanne M A ^a,b,c,d,e   Walczak, Pjotr ^a,b,c,d,e   Van Der Toorn, Annette ^a,b,c,d,e   Viergever, Max A ^a,b,c,d,e   Dijkstra, Christine D ^a,b,c,d,e   Bulte, Jeff W M ^a,b,c,d,e   De Vries, Helga E ^a,b,c,d,e   Blezer, Erwin L A ^a,b,c,d,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Department of Chemical and Biomolecular Engineering ^*  (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CELLULAR MIGRATION; CENTRAL NERVOUS SYSTEMS; DISEASE MODELS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; INFLAMMATORY DISEASE; INTRACELLULAR IRON; MULTIPLE SCLEROSIS; SIGNAL INTENSITIES; SUPERPARAMAGNETIC IRON OXIDES; SUPERPARAMAGNETIC PARTICLES; THERAPEUTIC AGENTS; ULTRA-SMALL;

BODY FLUIDS; MAGNETIC RESONANCE IMAGING; RESONANCE; SUPERPARAMAGNETISM;

IRON OXIDES;

DEXTRAN; FERUMOXTRAN 10; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; METHODOLOGY; MONOCYTE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT;

ANIMALS; CELLS, CULTURED; DEXTRANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MONOCYTES; MULTIPLE SCLEROSIS; RATS;

EID: 77958112097     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00016     Document Type: Article

References (29)

1. Drayer BP. Imaging of the aging brain. Part II. Pathologic conditions. Radiology 1988;166:797-806.
2. Gebarski SS, Gabrielsen TO, Gilman S, et al. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging. Ann Neurol 1985;17:469-74.
3. Kertesz A, Black SE, Nicholson L, Carr T. The sensitivity and specificity of MRI in stroke. Neurology 1987;37:1580-5.
4. Corot C, Petry KG, Trivedi R, et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004;39:619-25.
5. Dousset V, Ballarino L, Delalande C, et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadoliniumenhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol 1999;20:223-7.
6. Rausch M, Baumann D, Neubacher U, Rudin M. In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 2002;15:278-83.
7. Xu S, Jordan EK, Brocke S, et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 1998;52:549-58.
8. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17:484-99.
9. Oude Engberink RD, van der Pol SM, Döpp EA, et al. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007;243:467-74.
10. Stroh A, Zimmer C, Werner N, et al. Tracking of systemically administered mononuclear cells in the ischemic brain by highfield magnetic resonance imaging. Neuroimage 2006;33:886-97.
11. Al-Omaishi J, Bashir R, Gendelman HE. The cellular immunology of multiple sclerosis. J Leukoc Biol 1999;65:444-52.
12. de Vries HE, Kuiper J, de Boer AG, et al. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997;49:143-55.
13. Bruck W, Sommermeier N, Bergmann M, et al. Macrophages in multiple sclerosis. Immunobiology 1996;195:588-600.
14. Gilad AA, Walczak P, McMahon MT, et al. MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med 2008;60:1-7.
15. Walczak P, Kedziorek DA, Gilad AA, et al. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005;54:769-74.
16. Walczak P, Ruiz-Cabello J, Kedziorek DA, et al. Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2006;2:89-94.
17. Floris S, Ruuls SR, Wierinckx A, et al. Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 2002;127:69-79.
18. Bulte JW, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001;19:1141-7.
19. Schreibelt G, Musters RJ, Reijerkerk A, et al. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol 2006;177:2630-7.
20. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005;235:155-61.
21. Oude Engberink RD, van der Pol SM, Dopp EA, et al. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007;243:467-74.
22. Raynal I, Prigent P, Peyramaure S, et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004;39:56-63.
23. Metz S, Bonaterra G, Rudelius M, et al. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-8.
24. Walczak P, Kedziorek D, Gilad AA, et al. Magnetoelectroporation: ultrafast, one-step magnetic labeling of non-phagocytic cells without the need for transfection agents; Presented at the 13th Annual Meeting of the International Society for Magnetic Resonance in Medicine; 2005; Miami (FL).
25. Dousset V, Delalande C, Ballarino L, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999;41:329-33.
26. Floris S, Blezer EL, Schreibelt G, et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004;127:616-27.
27. Wu YJ, Muldoon LL, Varallyay C, et al. In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am J Physiol Cell Physiol 2007;293: C1698-708.
28. Bulte JW, De Jonge MW, Kamman RL, et al. Dextran-magnetite particles: contrast-enhanced MRI of blood-brain barrier disruption in a rat model. Magn Reson Med 1992;23:215-23.
29. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 2004;55:654-9.